Hershey Financial Advisers LLC purchased a new position in shares of Axon Enterprise, Inc. (NASDAQ:AXON - Free Report) during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 2,479 shares of the biotechnology company's stock, valued at approximately $1,473,000.
Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Corebridge Financial Inc. increased its position in shares of Axon Enterprise by 26.1% in the fourth quarter. Corebridge Financial Inc. now owns 24,139 shares of the biotechnology company's stock valued at $14,346,000 after buying an additional 5,002 shares in the last quarter. CMC Financial Group purchased a new stake in Axon Enterprise in the 4th quarter worth $217,000. Vanguard Group Inc. raised its position in Axon Enterprise by 3.4% during the fourth quarter. Vanguard Group Inc. now owns 8,446,437 shares of the biotechnology company's stock worth $5,019,886,000 after acquiring an additional 275,959 shares during the period. LPL Financial LLC raised its position in Axon Enterprise by 13.5% during the fourth quarter. LPL Financial LLC now owns 101,431 shares of the biotechnology company's stock worth $60,282,000 after acquiring an additional 12,052 shares during the period. Finally, Fortis Capital Management LLC purchased a new position in Axon Enterprise during the fourth quarter valued at $276,000. Institutional investors and hedge funds own 79.08% of the company's stock.
Axon Enterprise Trading Up 0.8 %
Shares of Axon Enterprise stock traded up $4.66 during trading hours on Tuesday, hitting $577.18. The company's stock had a trading volume of 439,520 shares, compared to its average volume of 835,219. The stock has a market cap of $44.23 billion, a price-to-earnings ratio of 149.14, a P/E/G ratio of 5.17 and a beta of 1.12. The company has a debt-to-equity ratio of 0.32, a quick ratio of 2.63 and a current ratio of 2.96. Axon Enterprise, Inc. has a twelve month low of $273.52 and a twelve month high of $715.99. The firm has a fifty day moving average of $591.92 and a 200-day moving average of $546.67.
Wall Street Analyst Weigh In
Several research firms recently weighed in on AXON. Craig Hallum downgraded shares of Axon Enterprise from a "buy" rating to a "cautious" rating in a research report on Monday, March 10th. TD Cowen initiated coverage on Axon Enterprise in a report on Wednesday, January 8th. They set a "buy" rating and a $700.00 target price for the company. Barclays reaffirmed a "hold" rating on shares of Axon Enterprise in a research note on Monday, March 10th. Northcoast Research cut Axon Enterprise from a "buy" rating to a "neutral" rating in a research report on Wednesday, February 19th. Finally, Robert W. Baird lifted their target price on shares of Axon Enterprise from $600.00 to $800.00 and gave the stock an "outperform" rating in a research note on Friday, December 6th. One research analyst has rated the stock with a sell rating, two have issued a hold rating and eleven have given a buy rating to the stock. According to data from MarketBeat.com, Axon Enterprise has a consensus rating of "Moderate Buy" and an average target price of $604.67.
Check Out Our Latest Analysis on AXON
Insider Buying and Selling at Axon Enterprise
In other news, Director Caitlin Elizabeth Kalinowski sold 450 shares of the firm's stock in a transaction on Thursday, January 2nd. The stock was sold at an average price of $604.07, for a total transaction of $271,831.50. Following the completion of the transaction, the director now directly owns 6,929 shares in the company, valued at $4,185,601.03. This trade represents a 6.10 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. Also, Director Jeri Williams sold 307 shares of the business's stock in a transaction on Monday, March 17th. The shares were sold at an average price of $552.72, for a total value of $169,685.04. Following the completion of the sale, the director now owns 1,627 shares in the company, valued at $899,275.44. This represents a 15.87 % decrease in their position. The disclosure for this sale can be found here. 6.10% of the stock is currently owned by corporate insiders.
Axon Enterprise Profile
(
Free Report)
Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.
Recommended Stories

Before you consider Axon Enterprise, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Axon Enterprise wasn't on the list.
While Axon Enterprise currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.